Monday, March 05, 2018

Equity Corporate Actions Alert #2018 - 40
(UPDATED) Information Regarding the Tender Offer for the Shares of Cascadian Therapeutics, Inc. (CASC)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:


The tender offer by Valley Acquisition Sub, Inc. (a wholly-owned subsidiary of Seattle Genetics, Inc.) to acquire all of the outstanding shares of Cascadian Therapeutics, Inc. (CASC) has expired. The subsequent merger has closed today, March 9, 2018. The details are as follows:

Company Name: Cascadian Therapeutics, Inc.
Issue: Common Stock
CUSIP: 14740B606
Symbol: CASC
Offer Price: $10.00 in cash per share
Marketplace Effective Date for Suspension: March 12, 2018


Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.